HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Ju Chen Selected Research

acetoacetyl-CoA synthetase

1/2017Identification of Potential Plasma Biomarkers for Nonalcoholic Fatty Liver Disease by Integrating Transcriptomics and Proteomics in Laying Hens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Ju Chen Research Topics

Disease

39Neoplasms (Cancer)
04/2024 - 09/2004
14Lung Neoplasms (Lung Cancer)
04/2024 - 01/2011
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 09/2008
9Neoplasm Metastasis (Metastasis)
01/2022 - 10/2006
8Stomach Neoplasms (Stomach Cancer)
06/2017 - 09/2004
7Inflammation (Inflammations)
08/2023 - 09/2008
5Adenocarcinoma of Lung
04/2024 - 01/2011
4Hypoxia (Hypoxemia)
08/2023 - 12/2016
4Carcinogenesis
01/2022 - 01/2013
4Hepatocellular Carcinoma (Hepatoma)
08/2021 - 01/2013
4Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 07/2010
3Atherosclerosis
01/2023 - 03/2020
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 01/2022
3Breast Neoplasms (Breast Cancer)
11/2022 - 01/2016
3Immune System Diseases (Immune Disorders)
01/2020 - 01/2014
2Ischemia
11/2023 - 12/2020
2Non-alcoholic Fatty Liver Disease
01/2022 - 01/2017
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2018
2Stroke (Strokes)
12/2020 - 01/2019
2Fibrosis (Cirrhosis)
01/2020 - 03/2013
2Genomic Instability
01/2019 - 01/2016
2Chondrosarcoma
11/2017 - 05/2015
2Infections
01/2010 - 12/2004
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2023
1Nervous System Diseases (Neurological Disorders)
09/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2023
1Biliary Atresia
01/2023
1Lymphocytosis
01/2023
1Leukemia
01/2023
1Carcinoma (Carcinomatosis)
01/2023
1Thrombophilia
07/2022
1Thrombosis (Thrombus)
07/2022

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
04/2024 - 09/2004
17Biomarkers (Surrogate Marker)IBA
04/2024 - 09/2004
10ProteomeIBA
01/2023 - 12/2004
9Phosphotransferases (Kinase)IBA
11/2023 - 01/2011
6Membrane Proteins (Integral Membrane Proteins)IBA
12/2015 - 10/2008
5PhosphoproteinsIBA
01/2023 - 09/2008
4Peptides (Polypeptides)IBA
01/2024 - 12/2015
4GlycopeptidesIBA
12/2021 - 01/2017
3Glucose (Dextrose)FDA LinkGeneric
11/2023 - 01/2013
3EnzymesIBA
08/2023 - 01/2013
3CytokinesIBA
08/2023 - 10/2015
3ChemokinesIBA
02/2023 - 01/2010
3Apolipoproteins E (ApoE)IBA
01/2023 - 03/2020
3Gefitinib (Iressa)FDA Link
01/2023 - 06/2015
3PhosphopeptidesIBA
01/2021 - 11/2010
3Reactive Oxygen Species (Oxygen Radicals)IBA
03/2020 - 11/2014
3Serum Amyloid A Protein (Serum Amyloid A)IBA
06/2017 - 09/2004
2ErbB Receptors (EGF Receptor)IBA
01/2024 - 10/2008
2AntibodiesIBA
10/2023 - 01/2013
2Messenger RNA (mRNA)IBA
09/2023 - 03/2015
2MicroRNAs (MicroRNA)IBA
08/2023 - 01/2019
2ApolipoproteinsIBA
01/2023 - 03/2020
24- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
01/2023 - 12/2021
2ibrutinibIBA
01/2023 - 01/2022
2VimentinIBA
01/2022 - 10/2006
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 03/2013
2TransferasesIBA
01/2020 - 11/2015
2Ligases (Synthetase)IBA
01/2020 - 12/2016
2UbiquitinIBA
01/2020 - 12/2016
2CalciumIBA
01/2019 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 01/2012
2AmphiregulinIBA
11/2017 - 05/2015
2Integrin alpha6beta1IBA
11/2017 - 05/2015
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2017 - 05/2015
2Tyrosine Kinase InhibitorsIBA
01/2017 - 06/2015
2imidazoleacetic acid (IMAC)IBA
01/2014 - 09/2008
2Fatty Acids (Saturated Fatty Acids)IBA
03/2013 - 01/2012
2Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2004 - 09/2004
1RoscovitineIBA
11/2023
1Oxygen (Dioxygen)IBA
11/2023
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2023
1Chimeric Antigen ReceptorsIBA
10/2023
1AntigensIBA
10/2023
1Rituximab (Mabthera)FDA Link
10/2023
1CollagenIBA
08/2023
1Collagen Type II (Type II Collagen)IBA
08/2023
1Chemokine CCL5IBA
02/2023
1Lactic Acid (Lactate)FDA LinkGeneric
02/2023
1cadherin 5IBA
01/2023
1Serine (L-Serine)FDA Link
01/2023
1G-Protein-Coupled Receptor Kinase 2IBA
01/2023
1VinculinIBA
01/2023
1CateninsIBA
01/2023
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2023
1duvelisibIBA
01/2023
1Matrix Metalloproteinase 7 (Matrilysin)IBA
01/2023
1Fibrinogen (Factor I)FDA Link
07/2022
1AnticoagulantsIBA
07/2022
15'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
01/2022
1AntioxidantsIBA
01/2022
1LigandsIBA
01/2022
1Sialic Acid Binding Immunoglobulin-like LectinsIBA
01/2022
1SialoglycoproteinsIBA
12/2021
1acetonitrileIBA
12/2021

Therapy/Procedure

12Therapeutics
10/2023 - 10/2008
3Drug Therapy (Chemotherapy)
03/2020 - 11/2014
2Immunotherapy
01/2023 - 01/2019
1Cell- and Tissue-Based Therapy (Cell Therapy)
10/2023